Table 4.

Comparison of African American (AA) and non-Hispanic white children with juvenile idiopathic arthritis-associated uveitis (JIA-U).

AA, n = 13White, n = 446p*
Demographic characteristics
  Age at time of study, yrs, mean ± SD12.3 ± 4.611.1 ± 4.50.352
  Sex, female, n (%)8 (61.5)345 (77.4)0.315
Disease characteristics
  Age at arthritis onset, yrs ± SD8.0 ± 5.14.2 ± 3.50.035*
  JIA subtype, n (%)0.138
    Systemic0 (0.0)2 (0.4)1.000
    Polyarticular RF-negative1 (7.7)108 (24.7)0.168
    Polyarticular RF-positive0 (0.0)3 (0.7)1.000
    Oligoarticular persistent5 (38.5)186 (42.7)0.815
    Oligoarticular extended2 (15.4)64 (14.7)0.917
    Psoriatic0 (0.0)31 (7.1)0.325
    Enthesitis-related4 (30.8)30 (6.9)0.001*
    Undifferentiated1 (7.7)13 (3.0)0.323
No. current active joints, mean ± SD0.9 ± 2.00.8 ± 1.60.879
< 5 joints ever affected, n (%)5 (41.8)202 (45.3)0.803
Imaging evidence of joint damage, n (%)5 (41.7)86 (23.1)0.135
Laboratory data, n (%)
  ANA-positive4 (44.4)69 (49.6)1.000
  RF-positive0 (0.0)2 (1.5)1.000
  HLA-B27–positive4 (40.0)43 (18.1)0.100
  ACPA-positive1 (20.0)3 (2.3)0.140
QOL measuresa
  Physician global assessment2.2 ± 1.91.2 ± 1.70.050
  CHAQ0.35 ± 0.600.26 ± 0.500.604
  Patient/parent pain scale score2.31 ± 2.182.02 ± 2.490.650
  Parent/subject overall well-being score2.38 ± 2.431.90 ± 2.100.417
Health-related QOL, n (%)
  Excellent2 (15.4)122 (27.8)0.323
  Very good8 (61.5)185 (42.1)0.164
  Good3 (23.1)116 (26.4)0.787
  Poor0 (0)15 (3.4)0.497
  Very poor0 (0)1 (0.2)1.000
Parent/subject assessment of disease activity2.38 ± 2.402.11 ± 2.630.689
  • * p < 0.05, chi-squared, 2-sample, or Wilcoxon rank-sum tests;

  • a Higher scores indicate worse disease. CHAQ: Childhood Health Assessment Questionnaire; RF: rheumatoid factor; ANA: antinuclear antibody; ACPA: anticitrullinated protein antibodies; QOL: quality of life.